COPD and Asthma Devices Global Market Report 2023: Sector to Reach $60.4 Billion by 2028 at a 5.66% CAGR
The COPD and asthma devices market was valued at US$ 43.4 Billion in 2022 and is projected to reach US$ 60.4 Billion by 2028, with a CAGR of 5.66%.
This growth is driven by factors like the increasing elderly population prone to respiratory disorders, rising instances of diseases due to smoking, and enhanced healthcare spending.
Moreover, innovations in medical solutions, such as portable drug delivery devices, are expected to further propel market development. The report segments the market by product type, indication, distribution channel, and region, highlighting North America, Asia-Pacific, and Europe as key areas.
- Market size expected to grow from US$ 43.4 Billion in 2022 to US$ 60.4 Billion by 2028.
- CAGR of 5.66% indicates strong growth potential.
- Increasing geriatric population contributing to market expansion.
- Rise in respiratory diseases due to smoking boosting device sales.
- Increased healthcare spending supporting market growth.
- Adoption of advanced medical solutions providing opportunities.
- None.
The global COPD and asthma devices market size reached
Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness.
On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.
COPD and Asthma Devices Market Trends:
The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices.
Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth.
The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome.
Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.
Key Market Segmentation:
Breakup by Product:
- Inhalers
- Drug Powdered Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
- Soft Mist Inhalers
- Nebulizers
- Compressor Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers
Breakup by Indication:
- Asthma
- COPD
Breakup by Distribution Channel:
- Retail Pharmacies
- Hospitals
- Online Pharmacies
Breakup by Region:
North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia - Others
Europe Germany France United Kingdom Italy Spain Russia - Others
Latin America Brazil Mexico - Others
Middle East andAfrica
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
5 Global COPD and Asthma Devices Market
6 Market Breakup by Product
7 Market Breakup by Indication
8 Market Breakup by Distribution Channel
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
Companies Mentioned
- Adherium Limited
Aristopharma Ltd. - AstraZeneca PLC
- Baxter International Inc.
Boehringer Ingelheim International GmbH Cohero Health Inc. - Koninklijke Philips N.V.
- Omron Corporation
Pari Respiratory Equipment Inc. - Recipharm AB
Verona Pharma plc .
For more information about this report visit https://www.researchandmarkets.com/r/ayfkrk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Fax (outside
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/copd-and-asthma-devices-global-market-report-2023-sector-to-reach-60-4-billion-by-2028-at-a-5-66-cagr-301782328.html
SOURCE
FAQ
What is the projected growth of the COPD and asthma devices market by 2028?
What was the market size of COPD and asthma devices in 2022?
What is the CAGR for the COPD and asthma devices market between 2022 and 2028?
Which region is expected to lead in the COPD and asthma devices market?
What factors are driving the growth of COPD and asthma devices?
